Related Experiment Video
Updated: Jul 19, 2025

Using the E1A Minigene Tool to Study mRNA Splicing Changes
Published on: April 22, 2021
NRF2 has a splicing regulatory function involving the survival of motor neuron (SMN) in non-small cell lung cancer
Qinqin Cui1, Wei Wang1, Akhileshwar Namani1
1Department of Biochemistry and Department of Thoracic Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, 310003, P. R. China.
Abstract:
The nuclear factor erythroid 2-like 2 (NFE2L2; NRF2) signaling pathway is frequently deregulated in human cancers. The critical functions of NRF2, other than its transcriptional activation, in cancers remain largely unknown. Here, we uncovered a previously unrecognized role of NRF2 in the regulation of RNA splicing. Global splicing analysis revealed that NRF2 knockdown in non-small cell lung cancer (NSCLC) A549 cells altered 839 alternative splicing (AS) events in 485 genes. Mechanistic studies demonstrated that NRF2 transcriptionally regulated SMN mRNA expression by binding to two antioxidant response elements in the SMN1 promoter. Post-transcriptionally, NRF2 was physically associated with the SMN protein. The Neh2 domain of NRF2, as well as the YG box and the region encoded by exon 7 of SMN, were required for their interaction. NRF2 formed a complex with SMN and Gemin2 in nuclear gems and Cajal bodies. Furthermore, the NRF2-SMN interaction regulated RNA splicing by expressing SMN in NRF2-knockout HeLa cells, reverting some of the altered RNA splicing. Moreover, SMN overexpression was significantly associated with alterations in the NRF2 pathway in patients with lung squamous cell carcinoma from The Cancer Genome Atlas. Taken together, our findings suggest a novel therapeutic strategy for cancers involving an aberrant NRF2 pathway.
Insights
Nuclear factor erythroid 2-like 2 (NRF2) regulates RNA splicing, impacting cancer. This study reveals NRF2
Area of Science:
- Molecular Biology
- Cancer Research
- Gene Regulation
Background:
- The nuclear factor erythroid 2-like 2 (NFE2L2; NRF2) pathway is often dysregulated in human cancers.
- Non-transcriptional roles of NRF2 in cancer, particularly in RNA processing, are largely unexplored.
- Understanding NRF2's functions beyond transcriptional activation is crucial for cancer therapy development.
Purpose of the Study:
- To investigate the role of NRF2 in regulating RNA splicing.
- To elucidate the molecular mechanisms underlying NRF2-mediated splicing control.
- To explore the therapeutic implications of targeting the NRF2 pathway in cancer.
Main Methods:
- Global alternative splicing analysis in NRF2-knockdown non-small cell lung cancer (NSCLC) cells.
- Mechanistic studies involving NRF2 binding to the SMN1 promoter and protein-protein interactions.
- Functional rescue experiments in NRF2-knockout cells and analysis of patient data (The Cancer Genome Atlas).
Main Results:
- NRF2 knockdown altered 839 alternative splicing events in 485 genes in NSCLC cells.
- NRF2 directly regulates SMN mRNA expression and interacts with SMN protein in nuclear bodies.
- SMN overexpression correlates with NRF2 pathway alterations in lung squamous cell carcinoma patients.
Conclusions:
- NRF2 plays a significant, previously unrecognized role in regulating RNA splicing.
- The NRF2-SMN interaction is a key mechanism controlling RNA splicing.
- Targeting the NRF2 pathway offers a potential novel therapeutic strategy for cancers with aberrant NRF2 signaling.
Related Concept Videos
RNA Splicing
Alternative RNA Splicing
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
Regulation of Nuclear Protein Sorting
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The...
lncRNA - Long Non-coding RNAs
Nonsense-mediated mRNA Decay
Usually, Upf3 binds to an Exon Junction Complex (EJC) at mRNA splice sites. If a ribosome fully translates the mRNA,...

